199 related articles for article (PubMed ID: 24860847)
21. Protein micro- and nano-capsules for biomedical applications.
Shimanovich U; Bernardes GJ; Knowles TP; Cavaco-Paulo A
Chem Soc Rev; 2014 Mar; 43(5):1361-71. PubMed ID: 24336689
[TBL] [Abstract][Full Text] [Related]
22. Carbohydrate nanocarriers in biomedical applications: functionalization and construction.
Kang B; Opatz T; Landfester K; Wurm FR
Chem Soc Rev; 2015 Nov; 44(22):8301-25. PubMed ID: 26278884
[TBL] [Abstract][Full Text] [Related]
23. DNA nanostructure-based imaging probes and drug carriers.
Zhan P; Jiang Q; Wang ZG; Li N; Yu H; Ding B
ChemMedChem; 2014 Sep; 9(9):2013-20. PubMed ID: 25045126
[TBL] [Abstract][Full Text] [Related]
24. [Peptide aptamers and nano-carriers for cancer therapy].
Shiba K
Gan To Kagaku Ryoho; 2009 Mar; 36(3):362-5. PubMed ID: 19295259
[TBL] [Abstract][Full Text] [Related]
25. Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics.
Lee NK; Lee EJ; Kim S; Nam GH; Kih M; Hong Y; Jeong C; Yang Y; Byun Y; Kim IS
J Control Release; 2017 Dec; 267():172-180. PubMed ID: 28821462
[TBL] [Abstract][Full Text] [Related]
26. Highly organized nanostructures for brain drug delivery--new hope or just a fad?
Labuzek K; Gorki K; Jaroszek H; Jarzabek K; Gabryel B; Okopien B
CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1271-85. PubMed ID: 24040789
[TBL] [Abstract][Full Text] [Related]
27. Self-assembling protein nanocages for modular enzyme assembly by orthogonal bioconjugation.
Berckman EA; Chen W
Biotechnol Prog; 2021 Sep; 37(5):e3190. PubMed ID: 34173352
[TBL] [Abstract][Full Text] [Related]
28. Ferritin Nanocages for Protein Delivery to Tumor Cells.
Palombarini F; Di Fabio E; Boffi A; Macone A; Bonamore A
Molecules; 2020 Feb; 25(4):. PubMed ID: 32070033
[TBL] [Abstract][Full Text] [Related]
29. Recent trends in drug delivery system using protein nanoparticles.
Sripriyalakshmi S; Jose P; Ravindran A; Anjali CH
Cell Biochem Biophys; 2014 Sep; 70(1):17-26. PubMed ID: 24668188
[TBL] [Abstract][Full Text] [Related]
30. Nanodiamond-insulin complexes as pH-dependent protein delivery vehicles.
Shimkunas RA; Robinson E; Lam R; Lu S; Xu X; Zhang XQ; Huang H; Osawa E; Ho D
Biomaterials; 2009 Oct; 30(29):5720-8. PubMed ID: 19635632
[TBL] [Abstract][Full Text] [Related]
31. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics.
Gu L; Faig A; Abdelhamid D; Uhrich K
Acc Chem Res; 2014 Oct; 47(10):2867-77. PubMed ID: 25141069
[TBL] [Abstract][Full Text] [Related]
32. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
[TBL] [Abstract][Full Text] [Related]
33. Microfluidics: a focus on improved cancer targeted drug delivery systems.
Khan IU; Serra CA; Anton N; Vandamme T
J Control Release; 2013 Dec; 172(3):1065-74. PubMed ID: 23933524
[TBL] [Abstract][Full Text] [Related]
34. Non-viral nanosystems for systemic siRNA delivery.
David S; Pitard B; Benoît JP; Passirani C
Pharmacol Res; 2010 Aug; 62(2):100-14. PubMed ID: 20006707
[TBL] [Abstract][Full Text] [Related]
35. Nanostructured lipid carriers (NLCs) for drug delivery and targeting.
Fang CL; Al-Suwayeh SA; Fang JY
Recent Pat Nanotechnol; 2013 Jan; 7(1):41-55. PubMed ID: 22946628
[TBL] [Abstract][Full Text] [Related]
36. The effects of polymeric nanostructure shape on drug delivery.
Venkataraman S; Hedrick JL; Ong ZY; Yang C; Ee PL; Hammond PT; Yang YY
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1228-46. PubMed ID: 21777633
[TBL] [Abstract][Full Text] [Related]
37. Applications and advancements of polysaccharide-based nanostructures for enhanced drug delivery.
Kareemi AF; Likhitkar S
Colloids Surf B Biointerfaces; 2024 Jun; 238():113883. PubMed ID: 38615389
[TBL] [Abstract][Full Text] [Related]
38. Surface-functionalized nanoparticles for controlled drug delivery.
Choi SW; Kim WS; Kim JH
Methods Mol Biol; 2005; 303():121-31. PubMed ID: 15923680
[TBL] [Abstract][Full Text] [Related]
39. A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells.
Toita R; Murata M; Abe K; Narahara S; Piao JS; Kang JH; Hashizume M
Chem Commun (Camb); 2013 Aug; 49(67):7442-4. PubMed ID: 23860596
[TBL] [Abstract][Full Text] [Related]
40. Monitoring controlled release of payload from gold nanocages using surface enhanced Raman scattering.
Tian L; Gandra N; Singamaneni S
ACS Nano; 2013 May; 7(5):4252-60. PubMed ID: 23577650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
